Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Estimating weekly excess mortality at sub-national level in Italy during the COVID-19 pandemic

Marta Blangiardo, Michela Cameletti, Monica Pirani, Gianni Corsetti, Marco Battaglini, View ORCID ProfileGianluca Baio
doi: https://doi.org/10.1101/2020.06.08.20125211
Marta Blangiardo
1MRC Centre for Environment and Health, Department of Epidemiology and Biostatistics, Imperial College London, Norfolk Place, London, W2 1PG, UK
Roles: Professor of Biostatistics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michela Cameletti
2Istat, Directorate for Social Statistics and Population Census, Via Cesare Balbo, 16, 00184 Rome, Italy
Roles: Associate Professor of Statistics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monica Pirani
3Department of Management, Economics and Quantitative Methods, University of Bergamo, via Salvecchio 19, 24129, Bergamo, Italy
Roles: Lecturer in Biostatistics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gianni Corsetti
4Department of Statistical Sciences, University College London, Gower Street, London, WC1E 6BT, UK
Roles: Statistical Researcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Battaglini
4Department of Statistical Sciences, University College London, Gower Street, London, WC1E 6BT, UK
Roles: Statistical Researcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gianluca Baio
Roles: Professor of Statistics and Health Economics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gianluca Baio
  • For correspondence: g.baio@ucl.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives To provide a sub-national analysis of excess mortality during the COVID-19 pandemic in Italy.

Design Population-based on all-cause mortality official data, available as counts by age and sex.

Setting The 7,904 municipalities in Italy.

Participants All residents in Italy in the years 2016 to 2020.

Main outcome measures All-cause mortality weekly rates for each municipality, based on the first four months of 2016 – 2019. Predicted all-cause weekly deaths and mortality rates at municipality level for 2020, based on the modelled spatio-temporal trends.

Results There was strong evidence of excess mortality for Northern Italy; Lombardia showed higher mortality rates than expected from the end of February, with 23,946 (23,013 to 24,786) total excess deaths. North-West and North-East regions showed higher mortality from the beginning of March, with 6,942 (6,142 to 7,667) and 8,033 (7,061 to 9,044) total excess deaths respectively. After discounting for the number of COVID-19-confirmed deaths, Lombardia still registered 10,197 (9,264 to 11,037) excess deaths, while regions in the North-West and North-East had 2,572 (1,772 to 3,297) and 2,047 (1,075 to 3,058) extra deaths, respectively. We observed marked geographical differences at municipality level. The city of Bergamo (Lombardia) showed the largest percent excess 88.9% (81.9% to 95.2%) at the peak of the pandemic. An excess of 84.2% (73.8% to 93.4%) was also estimated at the same time for the city of Pesaro (Central Italy), in stark contrast with the rest of the region, which does not show evidence of excess deaths.

Conclusions Our study gives a comprehensive picture of the evolution of all-cause mortality in Italy from 2016 to 2020 and describes the spatio-temporal differences in excess mortality during the COVID-19 pandemic. Our model shows heterogeneous impact of COVID-19, and it can be used to help policy- makers target measures to limit the burden on the health-care system as well as reducing social and economic consequences. Our probabilistic methodology is useful for real-time mortality surveillance, continuously monitoring local temporal trends and flagging where and when mortality rates deviate from the expected range, which might suggest a second wave of the pandemic.

Introduction

The total impact of the COVID-19 pandemic on mortality should be the least controversial outcome to measure. However, its analysis is complicated by the lack of real time cause specific data; a potential additional issue concerns the quality of coding on the death certificates, particularly in the earlier stages of the pandemic. Furthermore, there are important differences in the recording systems, both across and within countries (e.g. in the UK, England and Wales have consistently reported data on daily deaths based on different time of recording in comparison to Scotland and Northern Ireland [1]). In this context, estimating excess deaths for all causes with respect to past year trends has been used in several countries as an effective way to evaluate the total burden of the COVID-19 pandemic, [2–6] including direct COVID-19-related as well as indirect effects (e.g. people not being able to access health-care). At the same time, all-cause mortality is not affected by mis-coding on the death certificates. [7]

This approach can only present global pictures of the total burden of the first wave of the infection. Nevertheless, to understand the dynamics of the pandemic, we need to analyse data at sub-national level; this would allow to account for geographical differences due to the infectious nature of the disease, as well as those in the population characteristics and health system provision. Additionally, time trends can vary substantially, rendering comparisons even more complex. Recently, health authorities of each country have been urged to release mortality data at high spatial and temporal resolution to evaluate the pattern of the disease and to compare it with the expected trend from previous years. [8] Up to date, to the best of our knowledge, only two papers have analysed mortality at regional level in England and Wales [9] and in Italy, [10] while there are no comprehensive studies that have looked at the impact of COVID-19 at sub-national level.

In this paper, we present the first comprehensive study of excess mortality at sub-national level in Italy, one of the countries with the largest number of deaths for COVID-19 (as of 8 June 2020, 33,964 confirmed fatalities, making it the fourth most affected country in the world, in absolute terms); we consider municipalities as geographical unit and we model weekly number of deaths for all causes. A report by the Italian National Institute of Health [11] showed the characteristics of the epidemics, both in terms of cases and mortality, across Italian regions. Conversely, our objective is to provide the community with a scalable method to obtain high resolution temporal trends of excess deaths across municipalities, in order to highlight similarities and differences in space and time.

Methods

Study design

We used a spatio-temporal disease mapping approach to evaluate the excess mortality in Italy at municipality level, while detecting and predicting its evolution on a weekly basis. First, we modelled weekly mortality trends over the years 2016 – 2019, accounting for air temperature. We used these trends to predict the weekly- and municipality-specific mortality over the period 1 January to 28 April 2020. Then, we compared the observed mortality for this period with the model-based predictions. This allows us to quantify the excess, defined as the number of deaths from all causes relative to what it would have been expected in the absence of the COVID-19 outbreak, based on the model.

We performed separate analyses for males and females, as previous studies have found differences in mortality between sexes. [12,13] The main results are presented for the total population; we adjust for the age structure at municipality level and across the study period through an internal standardisation. [14] We calculated age-specific rates (0-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65-74, 75+) across the country for the period under study in 2016 – 2019 as these represent the all-cause mortality in years without the pandemic. We then applied the age-specific rates to the year-and age-specific population in each municipality to estimate the expected number of cases as denominator.

Data

We used official weekly mortality data, available from the Italian Institute of Statistics (ISTAT; source: https://www.istat.it/en/archivio/240106). The data included counts by age, sex and municipality of residence of the cases. All-cause mortality cases were recorded for the 7,904 municipalities that comprise the whole Italian territory. Administratively, the Italian municipalities are nested into 107 provinces, which are themselves grouped into 20 regions.

We used the weekly deaths in 2020, available from the same source, as a comparison with the values predicted from our model. Currently the 2020 data are only available on 7,251 municipalities, which cover 91.7% of the Italian territory and 93.4% of the Italian population; hence, we limit the comparison to this subset.

To capture the seasonal variability in death counts, we also included air temperature data (at 2 meters height), obtained from Copernicus ERA5 global weather and climate reanalysis dataset, [15] which combines a weather model with observational data from satellites and ground monitors to produce global hourly data at a 30 km grid spatial resolution. Operationally, we processed air temperature data within the Google Earth Engine cloud-based platform to obtain weekly series of air temperature for each Italian municipality.

Statistical methods

Municipality weekly trends for 2016 – 2019

In line with the approach typically considered for disease mapping, [16] we modelled the total number of deaths at the municipality level, separately for males and females, for each week and year using a Poisson distribution with age-adjusted expected number of cases as offset. We specified a Bayesian hierarchical model on the log mortality relative risk, which is a common approach to overcome the high variability in the estimates driven by the small numbers of cases, due to the high spatio-temporal resolution. [17] In order to capture changes in space, we assumed that the log relative risk for each municipality is smoothed locally through a conditional autoregressive structure, [18] which models similarity across neighboring municipalities. To capture the long-term temporal trend, we considered a year-specific random intercept and accounted for the potential non-linearity in the mortality relative risks through a weekly smooth effect, where each week is assumed to depend on the value of the previous one (order one random walk). As the temporal trend might be different in space, we allowed a different random walk for each province. Finally, as there is extensive evidence of a non-linear effect of temperature on mortality, [19,20] we included a smoothed effect on weekly temperature at municipality level, through a second order random walk, so that each week is influenced by the previous two.

The model has been estimated using Integrated Nested Laplace Approximation and the software R-INLA (www.r-inla.org). A full specification of the model structure and the underlying distributional assumptions and priors are presented in details in the Supplementary material.

Weekly death prediction for 2020

We used the output from the model for 2016 – 2019 to predict the number of deaths expected for each week of our follow up period. Specifically, for each municipality and week, we sampled 1000 values from the posterior predictive distribution, where the log relative risk is the linear combination of the corresponding spatial, temporal and temperature effects estimated given the data from 2016 – 2019. To report results at the province (regional) level, we summed each draw across the municipalities belonging to the same province (region). This simulation-based approach to the post-processing of the model output allows to fully characterise the uncertainty in the mortality rates and to propagate it in a principled way through to the predicted mortality counts.

We present plots of observed and predicted trends in mortality rates as well as maps and plots of percentage excess mortality, estimated as the difference between the observed number of deaths and the predicted number under current trends (based on past data and on the assumption that the pandemic did not occur), divided by the observed number.

Patients and Public Involvement

It was not appropriate or possible to involve patients or the public in the design, or conduct, or reporting, or dissemination plans of our research

Results

For males, the total number of deaths in the first four months of 2020 was 122,129, progressing from 6,278 in the week commencing on 1 January to 5,748 in the week commencing on the 22 April; for females the total number of deaths was 129,044, going from 6,633 to 6,614 during the same observation period. Nationally, the highest weekly death toll was of 11,301 in the week of 18 March and of 10,612 in the week of 25 March for males and females, respectively.

We present the trend in mortality rates split by five macro-areas: the North-West (Piemonte, Valle d’Aosta, Liguria); Lombardia; the North-East (Veneto, Trentino-Alto Adige, Friuli Venezia Giulia, Emilia- Romagna); the Centre (Lazio, Marche, Toscana and Umbria); and the South and major Islands (Abruzzo, Basilicata, Calabria, Campania, Molise, Puglia, Sardegna and Sicilia). These are consistent with the Eurostat classification, although we report Lombardia (which would normally be included in the North West) separately, as it was the most affected region (Figures 1 and 2). For both sexes, the model based on 2016 – 2019 predicts a slightly decreasing trend for the entire period, with the blue curve and the gray ribbon indicating respectively the mean and 95% interval estimate for the posterior predictive distribution of the number of deaths.

Fig 1:
  • Download figure
  • Open in new tab
Fig 1:

Trend for all cause mortality (males). The blue curve shows the posterior mean predicted from the 2016 – 2019 model, while the gray ribbon describes the posterior 95% interval; the observed number of deaths for 2020 are in red

Fig 2:
  • Download figure
  • Open in new tab
Fig 2:

Trend for all cause mortality (females). The blue curve shows the posterior predictive mean predicted from the 2016 – 2019 model, while the gray ribbon describes the posterior 95% interval; the observed number of deaths for 2020 are in red

Lombardia is the first region to show a sharp increase from the estimated trend, starting with males in the week of the 26 of February (observed rate = 22.6 per 100,000 vs upper limit of the 95% posterior interval = 22.1 per 100,000, with a posterior probability that the observed rates exceeds the estimated trend equal to 0.996). Mortality rates for males in the North-West and the North-East regions start to deviate substantially from the estimated trend a week after Lombardia (starting 4 March), while the Centre shows a small deviation from the week starting with 11 March and the South does not show substantial differences from the model estimates of the time trend. For females there is a lagged effect of the pandemic, with mortality rates deviating from the expected trend on the week of 4 March in Lombardia and 11 March in the North-East and the North-West. The Centre and South do not show any evidence of excess death. It is worth noting that at the end of our follow up, while sharply falling down, mortality rates are at the level of (or above) those normally observed at the beginning of January.

The extent of geographical differences is clear if looking at the trend in the percent excess mortality by province (Figures 3 and 4 for males and females, respectively). In the maps, darker shades of colour indicate larger percent excess mortality in a given week (we only present the progression from the week commencing on 26 February and for the provinces in the North-West, Lombardia and North-East; maps for all the 107 provinces are presented in Figure 1-4 in Supplementary material). There is a clear increasing darkening of the hot-spots at the heart of Lombardia (starting with Lodi and moving to the provinces of Cremona, Bergamo and Brescia), spreading mostly to the West into Piemonte, South-West into parts of Emilia-Romagna and mainly North-East into Trentino-Alto Adige. Interestingly, despite recording the first COVID-19 death in Italy, the region of Veneto (in the North East) is affected to a much lower extent, in comparison to neighbouring areas of Lombardia.

Fig 3:
  • Download figure
  • Open in new tab
Fig 3:

Map of the percent excess mortality for the provinces in the areas of North-West, Lombardia and North-East of Italy, weekly posterior predictive mean in 2020 for males. Period: 25 February - 28 April

Fig 4:
  • Download figure
  • Open in new tab
Fig 4:

Map of the percent excess mortality for the provinces in the areas of North-West, Lombardia and North-East of Italy, weekly posterior mean in 2020 for females. Period: 25 February - 28 April

Looking at specific municipalities the full extent of the geographical variation is even more striking: for males (Figure 5) the city of Piacenza (in Emilia-Romagna) is the first to reach the peak of the pandemic on the week starting on 11 March, when the observed mortality rates reach 177 per 100,000 residents, corresponding to an excess mortality of 86.9% (77.5% to 94.4%). Bergamo and Pesaro (in the region of Marche, in Central Italy) peak one week later, with mortality rates of 182 and 134 per 100,000, corresponding to an excess mortality of 88.9% (81.9% to 95.2%) and 84.2% (73.8% to 93.4%). Brescia shows a lagged peak, occurring over the weeks of 18 and 25 March and slightly lower mortality rates of 100 per 100,000, with a corresponding excess of 80.6% (70.8% to 88.5%). Meanwhile, Milano, (the second largest city in Italy and the capital of Lombardia) is characterised by a more diluted peak and much lower rates (51 per 100,000) with an excess of 63.2% (55.7% to 70.0%). Finally, Verona (located in Veneto and bordering the Lombard province of Brescia) shows rates barely above the expected interval in the peak weeks. This effect is possibly associated with the comprehensive measures and testing system implemented by the Veneto region to contain the epidemic. [21] Females show slightly lower rates and a peak around the same time, on the week of 18 March. The only exceptions are possibly represented by Milano, which still presents a diluted peak and Verona, which shows no clear evidence of a peak (Figure 6). The plot of the weekly excess mortality for the same municipalities is presented in Figures 5-6 in Supplementary material.

Fig 5:
  • Download figure
  • Open in new tab
Fig 5:

Trend for all cause mortality (males) in selected municipalities. The blue curve shows the posterior predictive mean predicted from the 2016 – 2019 model, while the gray ribbon describes the posterior 95% interval; the observed number of deaths for 2020 are in red

Fig 6:
  • Download figure
  • Open in new tab
Fig 6:

Trend for all cause mortality (females) in selected municipalities. The blue curve shows the posterior predictive mean predicted from the 2016 – 2019 model, while the gray ribbon describes the posterior 95% interval; the observed number of deaths for 2020 are in red

We combined the output from our analysis with official data on confirmed deaths for COVID-19 in Italy in the March-April period. Table 1 shows that if we remove the confirmed COVID-19 deaths, Lombardia is still left with a staggering 10,197 (9,264 to 11,037) excess deaths. These may be attributable to the fact that some individuals who would normally access the health care provision were somehow prevented or delayed in doing so during the past few months, resulting in deaths that would have occurred at a lower pace in normal circumstances. Similarly, but to a lower extent, the North-West and North-East show indirect effect of the pandemic on mortality, with an excess, after roughly discounting the confirmed COVID-19 fatality of 2,572 (1,772 to 3,297) and 2,047 (1,075 to 3,058) respectively. The Centre and the South show results that span across 0 in the 95% posterior interval, indicating lack of evidence of any difference in comparison to the estimated trends.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Observed and modelled excess mortality by macro-regions and by direct COVID-19 fatalities. For the modelled excess we summed the posterior draws across all the municipalities in each macro-area. We present the posterior mean and 95% interval.

Discussion

Statement of principal findings

In this paper we presented the first fully probabilistic analysis of the excess mortality at weekly sub- national level in Italy, one of countries with the highest number of deaths during the COVID-19 pandemic. We found that 2020 starts with lower rates than in previous years [13], but from the beginning of March 2020 there is evidence of an excess mortality compared with the trend in 2016 – 2019. However, our model suggests large geographical differences in the excess mortality across Italy; while it is now widely established that Lombardia is the most affected region (and one of the hardest hit, globally), we estimated large heterogeneity even with the closest neighbours. For instance, the city of Verona in Veneto, one of the regions in the North East, which borders Brescia (one of the hot-spots in Lombardia) was associated with mortality rates essentially in line with the historical trend. Similarly, Pesaro (in the central region of Marche) is associated with excess mortality rates that exceed those of Milan (the capital of Lombardia), while belonging to a region that has by and large not been severely affected. We compared our estimated excess mortality with the official statistics reported by ISTAT, which distinguish COVID-19 registered deaths from other causes. While it is impossible, nor is it our objective, to draw causal conclusions from the combination of these data, our analyses suggest a potential large increase in mortality, after discounting the confirmed COVID-19 deaths, particularly in Lombardia, but also in the other regions of Northern Italy. On the other hand, the Centre and the South of Italy do not show evidence of increased net mortality.

Strengths and weaknesses of the study

The specification of the model at municipality level, coupled with the inclusion of weekly non-linear terms, which are allowed to vary for each province, ensures that we can detect heterogeneity across space, while still retaining the flexibility to model the temporal pattern of mortality. This is consistent with typical modelling in disease mapping [22] and surveillance studies [23]. Additionally, we are framed in the same perspective as forecasting studies [24,25] and we take advantage of the Bayesian nature of our model to characterise the full uncertainty over the estimate of the rates to predict the weekly trends in 2020. At the same time, as our analysis estimates temporal trends for each municipality with the aim of predicting 2020 under the alternative scenario of the absence of a pandemic, we do not need to explicitly include covariates only varying in space. This is because their effect is captured by the municipality effect, which estimates the spatial heterogeneity in the rates. Nevertheless, we included weekly mean air temperature for each municipality to adjust the trends in mortality, which is crucial as 2020 was generally warmer than the previous years.

Our model has some limitations. At the time of writing, cause-specific mortality for the year 2020 was not available. Thus, while we were able to estimate the non-COVID-19-related mortality, we cannot disentangle the specific causes behind it. At the same time, we were not able to account for the potential reduction in the number of deaths decreasing during lockdown, due for example to a decrease of traffic accidents and injuries at work. This would lead to a conservative estimate of the excess mortality in our model. However, these causes generally account for less than 1% of the total deaths. Our results show that the excess mortality more than offsets that. Additionally, there have been several reports which have showed improvement in air quality during the lockdown in different countries, [26,27] leading to a consistent reduction of the pollution-related mortality. [28,29] However, the lack of real-time air pollution data covering the entire study region meant that we could not consider this aspect in the analyses.

Strengths and weaknesses in relation to other studies, discussing important differences in results

While an early comparative study on COVID-19-related mortality suggested that the region Lombardia was not heavily impacted by the epidemic wave, [30] in accordance with more recent studies, [31,32] we found that it was the most affected region, for both sexes. Other studies have tried to assess the impact of the pandemic using a lower geographical resolution, e.g. by considering national or regional data [9,10]. Conversely, our model is specified at the finest administrative level in Italy, which allows us to detect a very large heterogeneity both in space and time, in terms of the spread and the resulting impact of the pandemic on the health-care services. This would not have been picked up by an analysis at regional level.

Meaning of the study: possible explanations and implications for clinicians and policymakers

From the analysis of our results, it appears that the lockdown measures implemented by the Italian government have managed, over the course of several weeks, to contain the excess mortality, as evidenced by the steep decrease during the month of April. However, this is characterised by large spatial heterogeneity: while the Centre and the South return to mortality rates in line with the previous years, the regions of the North-West, North-East and, especially, Lombardia are still showing excess mortality by the end of our observation period. In the most affected region, males mortality rates by the end April return to levels normally observed at the beginning of January, while females rates remain still higher than expected. This suggests perhaps the necessity of staggered relaxation of the lockdown, in order to prevent a second wave and continue to limit the burden on the health-care system. As suggested elsewhere, [21] the aggressive programme of mass-testing implemented in Veneto is potentially a driving factor in the much lower excess mortality experienced by the region, in comparison to neighbouring areas such as Lombardia and, albeit to a lower extent, Trentino-Alto Adige.

The first confirmed COVID-19 death in Italy was on 21 of February and from the model there is evidence of a deviation from the expected temporal trend since the last week of February, with the national lockdown implemented on 9 of March. This suggests that our model is able to track the changes in the historical dynamics, thus making our framework particularly valuable to aid policy-making: as new data become available, the model can be used to identify when the rates return to the normal range, but also if and where they start deviating again due to the emergence of a potential second wave requiring for instance social restrictions targeted in space. Additionally, the modelling framework is a useful tool for prospective real-time surveillance, as it allows to effectively follow each municipality in time and flag unusual behaviours as soon as they happen, aiming at identifying potential new public health threats and contain them.

Unanswered questions and future research

In addition to providing estimates for the specific Italian case, the proposed modelling framework is highly scalable and adaptable. A natural extension of our work consists in the analysis of cause-specific mortality, when the data become available: this will lead to a better understanding of the trends in COVID- 19-related mortality, with respect to other competing mortality risks. Moreover, it would be possible to replicate almost without changes the model for other countries, once data become available at a relevant spatial resolution (e.g. local authorities, or even middle-super output areas in the UK).

Data Availability

All data are publicly available and can be downloaded at the ISTAT website.

https://www.istat.it/en/archivio/240106

Role of the funding source

The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Author contributions and competing interest statement

MBl, MC, MP and GB contributed equally to the design, literature search, statistical analyses, data interpretation and writing. GC and MBa were responsible for data collection and validation. All the authors have commented and approved the final manuscript. All the authors declare no competing interests.

References

  1. ↵
    Baio G, Blangiardo M. Why counting coronavirus deaths is not an exact science. The Guardian Published Online First: 2020. https://www.theguardian.com/commentisfree/2020/apr/19/coronavirus-deaths-data-uk
  2. ↵
    Modig K, Ebeling M. Excess mortality from COVID-19. Weeekly excess death rates by age and sex for Sweden. medRxiv Published Online First: 2020. doi:10.1101/2020.05.10.20096909
    OpenUrlAbstract/FREE Full Text
  3. Felix-Cardoso J, Vasconcelos H, Rodrigues P et al. Excess mortality during COVID-19 in five European countries and a critique of mortality analysis data. medRxiv Published Online First: 2020. doi:10.1101/2020.04.28.20083147
    OpenUrlAbstract/FREE Full Text
  4. Banerjee A, Pasea L, Harris S et al. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. The Lancet 2020;395:1715–25.
    OpenUrl
  5. Disease Control C for, (CDC) P. Excess deaths associated with COVID-19. 2020.https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm
  6. ↵
    Kontis V, Bennett JE, Parks RM et al. Age- and sex-specific total mortality impacts of the early weeks of the Covid-19 pandemic in England and Wales: Application of a Bayesian model ensemble to mortality statistics. medRxiv Published Online First: 2020. doi:10.1101/2020.05.20.20107680
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Coleman M, Di Carlo V, Ashton J et al. Reliable, real-world data on excess mortality are required to assess the impact of COVID-19. BMJopinion Published Online First: 2020.https://blogs.bmj.com/bmj/2020/05/07/reliable-real-world-data-on-excess-mortality-are-required-to-assess-the-impact-of-covid-19/
  8. ↵
    Leon DA, Shkolnikov VM, Smeeth L et al. COVID-19: a need for real-time monitoring of weekly excess deaths. The Lancet Published Online First: 2020. doi:10.1016/S0140-6736(20)30933-8
    OpenUrlCrossRefPubMed
  9. ↵
    Kontopantelis E, Mamas MA, Deanfield J et al. Excess mortality in England and Wales during the first wave of the COVID-19 pandemic. medRxiv Published Online First: 2020. doi:10.1101/2020.05.26.20113357
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Modi C, Boehm V, Ferraro S et al. How deadly is COVID-19? A rigorous analysis of excess mortality and age-dependent fatality rates in Italy. medRxiv Published Online First: 2020. doi:10.1101/2020.04.15.20067074
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Riccardo F, Ajelli M, Andrianou X et al. Epidemiological characteristics of COVID-19 cases in Italy and estimates of the reproductive numbers one month into the epidemic. medRxiv Published Online First: 2020. doi:10.1101/2020.04.08.20056861
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Grasselli G, Zangrillo A, Zanella A et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323:1574–81.
    OpenUrlPubMed
  13. ↵
    Michelozzi P, de’ Donato F, Scortichini M et al. Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020. Eurosurveillance 2020;25:2000620.
    OpenUrl
  14. ↵
    Waller LA. Disease mapping. Encyclopedia of Environmetrics 2006;2.
  15. ↵
    Copernicus Climate Change Service (C3S). ERA5: Fifth generation of ECMWF atmospheric reanalyses of the global climate. 2017.https://cds.climate.copernicus.eu/cdsapp#!/dataset/reanalysis-era5-single-levels?tab=overview
  16. ↵
    Lawson A, Lee D. Bayesian disease mapping for public health. In: Handbook of statistics. Elsevier 2017. 443–81.
  17. ↵
    Best N, Richardson S, Thomson A. A comparison of Bayesian spatial models for disease mapping. Statistical Methods in Medical Research 2005;14:35–59.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Besag J, York J, Mollié A. Bayesian image restoration, with two applications in spatial statistics. Annals of the Institute of Statistical Mathematics 1991;43:1–20.
    OpenUrlCrossRefWeb of Science
  19. ↵
    Gasparrini A, Guo Y, Sera F et al. Projections of temperature-related excess mortality under climate change scenarios. The Lancet Planetary Health 2017;1:e360–7.
    OpenUrl
  20. ↵
    Gasparrini A, Guo Y, Hashizume M et al. Mortality risk attributable to high and low ambient temperature: a multicountry observational study. The Lancet 2015;386:369–75.
    OpenUrlPubMed
  21. ↵
    Crisanti A, Cassone A. In one Italian town, we showed mass testing could eradicate the coronavirus. The Guardian Published Online First: 2020.https://www.theguardian.com/commentisfree/2020/mar/20/eradicated-coronavirus-mass-testing-covid-19-italy-vo
  22. ↵
    Boulieri A, Liverani S, Hoogh K de et al. A space–time multivariate Bayesian model to analyse road traffic accidents by severity. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2017;180:119–39.
    OpenUrl
  23. ↵
    Boulieri A, Bennett JE, Blangiardo M. A Bayesian mixture modeling approach for public health surveillance. Biostatistics Published Online First: 2018. doi:10.1093/biostatistics/kxy038
    OpenUrlCrossRef
  24. ↵
    Bennett JE, Li G, Foreman K et al. The future of life expectancy and life expectancy inequalities in England and Wales: Bayesian spatiotemporal forecasting. The Lancet 2015;386:163–70.
    OpenUrl
  25. ↵
    Foreman KJ, Li G, Best N et al. Small area forecasts of cause-specific mortality: application of a Bayesian hierarchical model to US vital registration data. Journal of the Royal Statistical Society: Series C (Applied Statistics) 2017;66:121–39.
    OpenUrl
  26. ↵
    Bauwens M, Compernolle S, Stavrakou T et al. Impact of coronavirus outbreak on NO2 pollution assessed using TROPOMI and OMI observations. Geophysical Research Letters Published Online First: 2020. doi:10.1029/2020GL087978
    OpenUrlCrossRef
  27. ↵
    Muhammad S, Long X, Salman M. COVID-19 pandemic and environmental pollution: A blessing in disguise? Science of The Total Environment 2020;728:138820.
    OpenUrl
  28. ↵
    Myllyvirta L, Thieriot H. 11,000 air pollution-related deaths avoided in Europe as coal, oil consumption plummet. London:: Centre for Research on Energy and Clean Air (CREA) 2020. https://energyandcleanair.org/air-pollution-deaths-avoided-in-europe-as-coal-oil-plummet/
  29. ↵
    Chen K, Wang M, Huang C et al. Air pollution reduction and mortality benefit during the COVID-19 outbreak in China. The Lancet Planetary Health Published Online First: 2020. doi:10.1016/S2542-5196(20)30107-8
    OpenUrlCrossRef
  30. ↵
    Signorelli C, Odone A, Gianfredi V et al. The spread of COVID-19 in six western metropolitan regions: a false myth on the excess of mortality in Lombardy and the defense of the city of Milan. Acta Biomedica 2020;91:23–30.
    OpenUrl
  31. ↵
    Odone A, Delmonte D, Scognamiglio T et al. COVID-19 deaths in Lombardy, Italy: data in context. The Lancet Public Health Published Online First: 2020. doi:10.1016/S2468-2667(20)30099-2
    OpenUrlCrossRef
  32. ↵
    Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? The Lancet Published Online First: 2020. doi:10.1016/S0140-6736(20)30627-9
    OpenUrlCrossRefPubMed
Back to top
PreviousNext
Posted June 09, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Estimating weekly excess mortality at sub-national level in Italy during the COVID-19 pandemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Estimating weekly excess mortality at sub-national level in Italy during the COVID-19 pandemic
Marta Blangiardo, Michela Cameletti, Monica Pirani, Gianni Corsetti, Marco Battaglini, Gianluca Baio
medRxiv 2020.06.08.20125211; doi: https://doi.org/10.1101/2020.06.08.20125211
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Estimating weekly excess mortality at sub-national level in Italy during the COVID-19 pandemic
Marta Blangiardo, Michela Cameletti, Monica Pirani, Gianni Corsetti, Marco Battaglini, Gianluca Baio
medRxiv 2020.06.08.20125211; doi: https://doi.org/10.1101/2020.06.08.20125211

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (423)
  • Anesthesia (97)
  • Cardiovascular Medicine (902)
  • Dentistry and Oral Medicine (171)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (408)
  • Epidemiology (8810)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1871)
  • Geriatric Medicine (179)
  • Health Economics (389)
  • Health Informatics (1294)
  • Health Policy (644)
  • Health Systems and Quality Improvement (495)
  • Hematology (207)
  • HIV/AIDS (397)
  • Infectious Diseases (except HIV/AIDS) (10591)
  • Intensive Care and Critical Care Medicine (565)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1770)
  • Nursing (105)
  • Nutrition (267)
  • Obstetrics and Gynecology (344)
  • Occupational and Environmental Health (461)
  • Oncology (968)
  • Ophthalmology (285)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (265)
  • Pediatrics (560)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (221)
  • Psychiatry and Clinical Psychology (1847)
  • Public and Global Health (3998)
  • Radiology and Imaging (657)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (537)
  • Rheumatology (216)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (167)
  • Surgery (199)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)